Craig Moore v. BASF Corporation
Opinion
IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT United States Court of Appeals Fifth Circuit
FILED
November 15, 2013
No. 13-30281
Lyle W. Cayce
Clerk
CRAIG MOORE, Individually and on behalf of minor child, A.D.M.; TONI JEANNE LABAT MOORE, Individually and on behalf of minor child A.D.M,
Plaintiffs-Appellants,
v.
INTERNATIONAL PAINT, L.L.C.,
Defendant-Appellee.
Appeal from the United States District Court for the Eastern District of Louisiana Civil Action No. 2:11-CV-1001
Before STEWART, Chief Judge, and DeMOSS and CLEMENT, Circuit Judges. PER CURIAM:* Appellants Craig Moore (“Moore”) and Toni Jeanne Labat Moore sued Appellee International Paint, L.L.C. (“IP”) under the Louisiana Products Liability Act (“LPLA”), alleging that Moore developed multiple myeloma due to his exposure to benzene contained in IP’s paints and paint thinners during his work at the Avondale Shipyards (“Avondale”) from 1988 to 1990. In support of their claims, Appellants retained Dr. Bhaskar Kura to provide expert
* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5TH CIR. R. 47.5.4.
No. 13-30281
testimony concerning, among other things, Moore’s cumulative benzene exposure while using IP’s products at Avondale.
After Dr. Kura submitted his expert report, IP filed a motion in limine to exclude Dr. Kura’s opinion under Federal Rule of Evidence 702 and Daubert v. Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). On November 30, 2012, the district court issued a 21-page order granting the motion. Among other things, the district court found that Dr. Kura’s opinion as to Moore’s cumulative benzene exposure was insufficiently reliable to pass muster under Daubert because Dr. Kura lacked a sufficient factual basis for his conclusions. Five days later, the court granted IP’s motion for summary judgment with respect to all the LPLA claims, partly on the ground that without Dr. Kura’s testimony, the Appellants could not prove essential elements of those claims. On appeal, Appellants contend that the district court erred in excluding Dr. Kura’s testimony and granting IP’s motion for summary judgment. For the following reasons, we AFFIRM.
I.
This court reviews rulings on the admissibility of expert testimony for abuse of discretion. Moore v. Ashland Chem. Inc., 151 F.3d 269, 274 (5th Cir. 1998) (en banc). “[W]e have recognized that district courts are given wide latitude in determining the admissibility of expert testimony, and the discretion of the trial judge will not be disturbed on appeal unless manifestly erroneous.” United States v. Cooks, 589 F.3d 173, 179 (5th Cir. 2009) (internal alteration and quotation marks omitted). In particular, “a district court has broad discretion to determine whether a body of evidence relied upon by an expert is sufficient to support that expert’s opinion.” Knight v. Kirby Inland Marine Inc., 482 F.3d 347, 354 (5th Cir. 2007).
Accordingly, we cannot reverse the district court’s decision to exclude Dr.
Kura’s opinion unless we find that the court committed a “plain and
No. 13-30281
indisputable” error “that amounts to a complete disregard of the controlling law.” Guy v. Crown Equip. Corp., 394 F.3d 320, 325 (5th Cir. 2004) (quoting Venegas-Hernandez v. Sonolux Records, 370 F.3d 183, 195 (1st Cir. 2004)) (internal quotation marks omitted). Further, although the district court’s summary judgment order relied primarily on its exclusion of Dr. Kura’s opinion as to the amount of benzene in IP’s products, neither party disputes that the Appellants cannot succeed on their LPLA claims without Dr. Kura’s testimony concerning Moore’s cumulative benzene exposure. Indeed, in their brief, 1 the Appellants concede that “[t]he district court’s grant of summary judgment was a foregone conclusion after it granted IP’s motion in limine and excluded the testimony of Dr. Kura” and that “[w]ithout Dr. Kura’s testimony, [Appellants] had no expert to testify that . . . Moore had been harmed as a result of the products’ unreasonably dangerous characteristics.”
II.
Among the conditions imposed by the Federal Rules of Evidence on the admissibility of expert opinion testimony is that the testimony be “based on sufficient facts or data.” FED. R. EVID. 702(b). Under the framework explained in the Supreme Court’s Daubert decision, “Rule 702 assigns to the district judge a gatekeeping role to ensure that scientific testimony is both reliable and relevant.” Johnson v. Arkema, Inc., 685 F.3d 452, 459 (5th Cir. 2012) (internal quotation marks omitted). The Daubert reliability analysis applies to, among other things, “the facts underlying the expert’s opinion.” Knight 482 F.3d at 355 (internal quotation marks omitted). In particular, an opinion based on “insufficient, erroneous information,” fails the reliability standard. Paz v. Brush Engineered Materials, Inc., 555 F.3d 383, 389 (5th Cir. 2009) (affirming exclusion of expert opinion that relied on false assumptions rebutted by
1 Appellants did not submit a reply brief.
No. 13-30281
undisputed record evidence). Although the Daubert reliability analysis is flexible and the proponent of the expert evidence need not satisfy every one of its factors, United States v. Hicks, 389 F.3d 514, 525 (5th Cir. 2004), “the existence of sufficient facts . . . is in all instances mandatory,” Hathaway v. Bazany, 507 F.3d 312, 318 (5th Cir. 2007).
Of course, “[w]hen facts are in dispute, experts sometimes reach different conclusions based on competing versions of the facts.” FED. R. EVID. 702 advisory committee’s note. Generally, the “fact-finder is entitled to hear [an expert’s] testimony and decide whether . . . the predicate facts on which [the expert] relied are accurate.” Pipitone v. Biomatrix, Inc., 288 F.3d 239, 250 (5th Cir. 2002). At the same time, however, expert testimony that relies on “completely unsubstantiated factual assertions” is inadmissible. Hathaway, 507 F.3d at 319 n.4. When an expert’s testimony is “not based upon the facts in the record but on altered facts and speculation designed to bolster [a party’s] position,” the trial court should exclude it. Guillory v. Domtar Indus., Inc., 95 F.3d 1320, 1331 (5th Cir. 1996).
III.
The district court identified numerous aspects of Dr. Kura’s cumulative exposure analysis that either had no support in the record or were flatly contradicted by all the available evidence. In particular, the district court noted the following:
Dr. Kura estimated the total number of hours Moore spent in proximity to the products allegedly containing benzene in 1988 (when the bulk of the alleged exposure took place) by dividing Moore’s total earnings from his work at Avondale by an hourly rate of $6.00. The undisputed evidence, however, showed that Moore was paid at hourly rates of $6.99, $7.44, and $8.00 that year.
No. 13-30281
Dr. Kura’s analysis assumed that when Moore was using IP’s products, he was always indoors. In his deposition testimony, which was the only evidence on this point, Moore stated that he used IP’s deck grey paint and IP’s paint thinner outdoors while working at Avondale. On top of his erroneous assumption that Moore only used IP’s products indoors, Dr. Kura also assumed that the indoor spaces where Moore worked were always unventilated. The available evidence on this point came from the deposition testimony of Avondale employee Danny Joyce as well as from Moore’s deposition. Joyce testified that Avondale had an extensive ventilation system, while Moore’s testimony was that the ventilation was good at times and nonexistent at other times. There was nothing in the record to suggest that Moore always worked without ventilation.
Free access — add to your briefcase to read the full text and ask questions with AI
Craig Moore v. BASF Corporation (Craig Moore v. BASF Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.